2Amsterdam

News

November 4, 2025

New office, new energy: Jesse Zijlma and Arno Voerman look back on first year in Amsterdam

Managing partner Jesse Zijlma and FinTech partner Arno Voerman reflect on the first year, discussing the motivations, the development of the team and the practice, and their ambitions for the future.
Read more
October 30, 2025
Agri & Food Corporate / M&A Retail

BarentsKrans welcomes Meltem Koning-Gungormez as a partner

As of 1 November 2025, Meltem Koning-Gungormez will join BarentsKrans as a partner, based in the firm’s Amsterdam Zuidas office.
Read more
June 30, 2025
Cartel Damages Corporate / M&A Corporate Litigation Healthcare Public & Social sector

BarentsKrans appoints in-house talent Anne-Rieke Brons-van der Linden and Tom Hoyer as partners

Anne-Rieke Brons-van der Linden and Tom Hoyer will join BarentsKrans’ partner group as of 1 July 2025. With their expertise and enthusiasm, they will strengthen the corporate law practice and the litigation practice
Read more
June 5, 2025
IP & Technology Patents & Technology

BarentsKrans moves up to Silver band in IAM Patent 1000 ranking

BarentsKrans has been promoted from Bronze to Silver in the 2025 ranking of IAM Patent 1000.
Read more
March 26, 2025
Agri & Food Arbitration Banking & Finance Commercial Litigation Corporate / M&A Data & Privacy Employment Law EU & Competition Healthcare IP & Technology Patents & Technology Private Equity & Venture Capital Real Estate Retail Tenancy Law Trade marks, designs and advertising

Excellent rankings for BarentsKrans in Legal 500

Today, The Legal 500 published its rankings for 2025. This year, BarentsKrans has been included in the guide with a total of 16 practice groups.
Read more
March 20, 2025
Arbitration Commercial Litigation Corporate / M&A Corporate Litigation Employment Law EU & Competition Financial Litigation IP & Technology Mass Litigation Patents & Technology Real Estate Supreme Court Litigation

BarentsKrans again recommended in Chambers and Partners Europe 2025

BarentsKrans has been included in the renowned international ranking with eight practice groups, fifteen individuals and excellent reviews.
Read more
February 13, 2025
Arbitration Commercial Litigation Corporate / M&A IP & Technology Mass Litigation Supreme Court Litigation Trade marks, designs and advertising

Excellent rankings in Chambers Global 2025 for BarentsKrans

We are very pleased to share that we have been ranked in Chambersandpartners Global 2025! This year’s guide recommends five practice areas and six individuals.
Read more
January 6, 2025
Corporate / M&A Notarial Property and Property Transactions Real Estate

BarentsKrans welcomes real estate civil-law notary / partner Leon Hoppenbrouwers and appoints Koen van Wijk as partner

BarentsKrans welcomes real estate civil-law notary/partner Leon Hoppenbrouwers and appoints Koen van Wijk as partner
Read more
December 20, 2024
Cartel Damages EU & Competition

BarentsKrans ‘highly recommended’ in latest Global Competition Review publication

Read more
December 6, 2024
Banking & Finance FinTech & Payments

BarentsKrans recognized as leading law firm in FinTech

On 5 December 2024 Chambers & Partners released its annual ranking of leading law firms and lawyers in FinTech. Both our firm and partners Marc Elshof and Arno Voerman have been recognized in the prestigious Chambers FinTech Guide 2025. Both our firm and Arno Voerman have received a band 1 ranking. Partner Marc Elshof, previously listed as ‘up and coming’, has now been elevated to band 4.
Read more
November 1, 2024
Banking & Finance Employment Law

BarentsKrans strengthens Amsterdam office with two new partners

With Martijn van der Vliet (banking & finance) and Homme ten Have (employment), BarentsKrans is strengthening its Zuidas office, which opened 1 November 2024.
Read more
October 4, 2024
IP & Technology Patents & Technology

IP & Technology team recommended in JUVE Patent 2024

BarentsKrans’ IP & Technology team is once again recommended in JUVE Patent’s rankings this year. JUVE names the team’s strong focus on pharmaceutical patents, especially for generic drug companies.
Read more